跳至主要内容
临床试验/NCT01598701
NCT01598701已完成4 期

The Opioid-Sparing and Analgesic Effects of IV Acetaminophen in Craniotomy: A Prospective, Randomized, Placebo-Controlled, Double-Blind Study

The University of Texas Health Science Center, Houston1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2012年5月2日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
已完成
入组人数
100
试验地点
1
主要终点
Post-Operative Opioid Requirement

研究概览

简要总结

The purpose of this study is to assess the use of intravenous Acetaminophen (OFIRMEV) as an effective adjunct therapeutic agent in patients undergoing craniotomy.

详细描述

General anesthesia will be induced by bolus administration of propofol (1.5-2.5 mg/kg IV), and fentanyl (2-3 µg/kg IV). Neuromuscular blockade will be achieved with bolus administration of rocuronium, vecuronium, or succinylcholine. Once the endotracheal tube is secured in place, the patient will be mechanically ventilated to an end-tidal CO2 of 35 mmHg. Additional procedures will include radial arterial line placement for invasive arterial blood pressure monitoring, as well as additional large-bore peripheral IV placements, or central line placement, if indicated. Anesthesia will be maintained with desflurane, propofol, and remifentanil.

Once general anesthesia has been induced, but prior to the first surgical incision, the first dose of the interventional agent will be administered. Repeat doses will be administered every 6 hours until 24 hours from the time that the patient enters the PACU, for a total of up to 6 doses. Once the patient has been positioned and prepped for surgery, the surgeon will infiltrate the scalp with bupivacaine 0.5% with epinephrine 1:200,000 (15-20 ml) before skin incision.

No other opioids or agents with analgesic properties (e.g., ketorolac, dexmedetomidine, ketamine) will be administered at any time during the operation. Additional medications that will be routinely administered for this procedure include dexamethasone 8-12mg IV prior to incision, and ondansetron 4mg IV at skin closure. Anticonvulsant drugs will be administered at the surgeon's request.

Emergence and extubation will occur at the completion of the case per standard guidelines. The time of remifentanil infusion discontinuation and time of extubation will be noted. If necessary, extubation may occur in the post anesthesia recovery unit (PACU); otherwise, extubation will occur in the operating room.

The patient will then be taken directly to the PACU. Inability to extubate a patient within two hours of completion of surgery will result in their withdrawal from the study. Once in the PACU, immediate postoperative vital signs will be recorded, including blood pressure, heart rate, respiratory rate, oxygen saturation, and RASS score.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Supportive Care
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 120 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Undergoing Craniotomy for Supratentorial Tumor Resection
  • Weight between 50 and 120 kilograms
  • ASA Physical Status I-III
  • Be able to communicate verbally
  • Be able to use Visual Analog Score

排除标准

  • Allergies to acetaminophen, morphine or any of the anesthetic agents required by the protocol.
  • Use of opioids, tramadol, benzodiazepines, or gabapentin on a daily basis for > 7 days prior to the day of surgery.
  • Use of acetaminophen, NSAIDs, or any other analgesic medication in the 12 hours immediately prior to study enrollment.
  • Hepatic insufficiency (elevated transaminases > 1.5 times the upper limit of normal) or renal insufficiency (plasma creatinine > 2mg/dl).
  • Known or suspected history of alcohol or illicit drug abuse.
  • Pregnant or breast-feeding.
  • Surgical plan for infratentorial (suboccipital) craniotomy.
  • Plan for neurophysiologic monitoring that precludes the use of neuromuscular blockade.
  • Inability to communicate due to a language barrier, impaired consciousness, cognitive defect or intellectual disability.
  • Uncontrolled Hypertension

研究组 & 干预措施

Intravenous Acetaminophen

Experimental

Patients will be receive doses of 1000 mg/100 mL of IV Acetaminophen (OFIRMEV). The drug will be infused over 15 minutes.

干预措施: Acetaminophen (Drug)

Placebo

Placebo Comparator

Patients will be given 100 mL normal saline placebos at scheduled time intervals in place of IV acetaminophen.

干预措施: Placebo (Drug)

结局指标

主要结局

Post-Operative Opioid Requirement

时间窗: 24 hours post-operatively

Opioid Consumption will be monitored in the first 24 post-operative hours. All non-opioid analgesics are disallowed. Total opioid consumption was calculated based on morphine equivalents (MEs), where 1 mg of IV morphine was equivalent to 1 ME, and 1 mg IV hydromorphone was calculated as 7 MEs.

次要结局

  • Time for Patient to Meet Post-anesthesia Care Unit (PACU) Discharge Criteria(From time of entry to PACU to time to meet PACU discharge criteria, an average of 12 minutes)
  • Post-Operative Pain(24 Hours Post-Operatively)
  • Time to Extubation at Emergence From Anesthesia(Time from of discontinuation of anesthetic to time of extubation, an average of 7 minutes)
  • Post-Operative Side Effects(24 Hours Post-Operatively)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carlos Artime

Assistant Professor - Anesthesiology

The University of Texas Health Science Center, Houston

研究点 (1)

Loading locations...

相似试验